Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.

Bibiana S BogerNara L QueirozPaulo E P NoriegaMaicon C CanutoMatheo Augusto Morandi StumpfCintia CercatoMarcio C ManciniMaria E de Melo

Published in: Obesity surgery (2023)

Topiramate (alone or associated with sibutramine) and orlistat (alone or in combination) promoted significant weight loss after 2 years of use in patients submitted to bariatric surgery with weight regain.

Keyphrases

weight loss
bariatric surgery
gastric bypass
roux en y gastric bypass
end stage renal disease
obese patients
body mass index
newly diagnosed
ejection fraction
chronic kidney disease
physical activity
weight gain
prognostic factors
peritoneal dialysis
type diabetes
body weight
drug induced
replacement therapy